Dimedone → HCID 22260507, compound

HRID 1610005Notes

Reaction equation

HRID 1610005 reaction equation
C(O[C:5]([N:7]1[CH2:11][CH2:10][C:9]([C:32]#[N:33])([NH:12][C:13](=[O:31])[CH:14]([NH:22][C:23]([N:25]2[CH2:30][CH2:29][O:28][CH2:27][CH2:26]2)=[O:24])[CH2:15][CH:16]2[CH2:21][CH2:20][CH2:19][CH2:18][CH2:17]2)[CH2:8]1)=O)C=C.[CH3:34][C:35]1([CH3:43])[CH2:42]C(=O)[CH2:39][C:37](=[O:38])[CH2:36]1>C(Cl)Cl.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[C:32]([C:9]1([NH:12][C:13]([CH:14]([NH:22][C:23]([N:25]2[CH2:30][CH2:29][O:28][CH2:27][CH2:26]2)=[O:24])[CH2:15][CH:16]2[CH2:21][CH2:20][CH2:19][CH2:18][CH2:17]2)=[O:31])[CH2:10][CH2:11][N:7]([C:5]2[CH2:34][C:35]([CH3:43])([CH3:42])[CH2:36][C:37](=[O:38])[CH:39]=2)[CH2:8]1)#[N:33]

Participants

5

Procedure

3-Cyano-3-{3-cyclohexyl-2-[(morpholine-4-carbonyl)-amino]-propionylamino}-pyrrolidine-1-carboxylic acid (2-propen-1-yl) ester (1.35 g, 2.93 mmol, 1.00 equiv) was dissolved in 35 mL of CH2Cl2 along with dimedone (3.30 g, 23.5 mmol, 8.03 equiv). Pd(PPh3)4 (0.25 g, 0.22 mmol, 0.07 equiv) was added and the suspension was stirred at room temperature for 3.5 h. The reaction mixture was concentrated and taken up into EtOAc (100 mL) and extracted with 1 N HCl (2×50 mL). Concentration of the organic phase and purification of the crude mixture by reverse-phase HPLC provide the product as two separate diastereomers; MS, m/z 500=M+1.

Workup

  1. concentrationThe reaction mixture was concentrated
  2. extractionextracted with 1 N HCl (2×50 mL)
  3. customConcentration of the organic phase and purification of the crude mixture by reverse-phase HPLC
  4. customprovide the product as two
  5. customseparate diastereomers

Sources & evidence

ORD record
ord-9217526b1d484a568d9ef6ec7cac2538
Source dataset
uspto-grants-2006_01
Patent number
US06982272B2

Reaction notes

Loading…